首页> 美国卫生研究院文献>Nature Communications >Modular pathway rewiring of Saccharomyces cerevisiae enables high-level production of L-ornithine
【2h】

Modular pathway rewiring of Saccharomyces cerevisiae enables high-level production of L-ornithine

机译:酿酒酵母的模块化途径重新布线使L-鸟氨酸的大量生产成为可能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Baker's yeast Saccharomyces cerevisiae is an attractive cell factory for production of chemicals and biofuels. Many different products have been produced in this cell factory by reconstruction of heterologous biosynthetic pathways; however, endogenous metabolism by itself involves many metabolites of industrial interest, and de-regulation of endogenous pathways to ensure efficient carbon channelling to such metabolites is therefore of high interest. Furthermore, many of these may serve as precursors for the biosynthesis of complex natural products, and hence strains overproducing certain pathway intermediates can serve as platform cell factories for production of such products. Here we implement a modular pathway rewiring (MPR) strategy and demonstrate its use for pathway optimization resulting in high-level production of L-ornithine, an intermediate of L-arginine biosynthesis and a precursor metabolite for a range of different natural products. The MPR strategy involves rewiring of the urea cycle, subcellular trafficking engineering and pathway re-localization, and improving precursor supply either through attenuation of the Crabtree effect or through the use of controlled fed-batch fermentations, leading to an L-ornithine titre of 1,041±47 mg l−1 with a yield of 67 mg (g glucose)−1 in shake-flask cultures and a titre of 5.1 g l−1 in fed-batch cultivations. Our study represents the first comprehensive study on overproducing an amino-acid intermediate in yeast, and our results demonstrate the potential to use yeast more extensively for low-cost production of many high-value amino-acid-derived chemicals.
机译:贝克酵母啤酒酵母是一家有吸引力的细胞工厂,用于生产化学物质和生物燃料。通过重建异源生物合成途径,该细胞工厂已生产出许多不同的产品。然而,内源性代谢本身涉及许多具有工业价值的代谢产物,因此对确保确保有效地将碳通道传导到这些代谢产物的内源性途径的去调节是非常重要的。此外,这些中的许多可以用作复杂天然产物的生物合成的前体,因此过量生产某些途径中间体的菌株可以用作生产此类产物的平台细胞工厂。在这里,我们实施了模块化途径重布线(MPR)策略,并展示了其在途径优化中的用途,从而导致了L-鸟氨酸的高产,L-精氨酸生物合成的中间体和一系列不同天然产物的前体代谢产物。 MPR策略涉及尿素循环的重新布线,亚细胞运输工程和途径的重新定位,以及通过减弱Crabtree效应或通过使用受控的分批分批发酵来改善前体供应,从而导致L-鸟氨酸滴度为1,041 ±47flamg l -1 在摇瓶培养中的产量为67 mg(g葡萄糖) -1 ,滴度为5.1 g l -1 < / sup>在分批补料栽培中。我们的研究代表了关于在酵母中过量生产氨基酸中间体的首个综合研究,我们的结果证明了潜在地更广泛地使用酵母来低成本生产许多高价值氨基酸衍生的化学品。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号